Delivery Order SPE2DB22D1202-SPE2DB24FUVQ8
- Not listed
- This is a delivery order with a firm fixed price valued at $86,637.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of pharmaceutical products, specifically MENQUADFI VIAL 0.5ML, to support various government agencies and healthcare programs. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor in the United States. The $3,507.65 firm fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a medical product. The contract has a period of performance through September 27, 2024 and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
- This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML medical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office Division. The $1,756.20 firm fixed price delivery order was placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS pharmaceutical products to the U.S. government. The $1,601.99 firm fixed price Delivery Order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $11,437.35 firm-fixed-price contract is for the supply of 4565452753 MENQUADFI VIAL 0.5ML pharmaceutical products. The award has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that supports various government agencies and healthcare programs through multiple indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $12,996.00 firm fixed price delivery order is for the provision of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as medical materials such as syringes, vials, test...
- This federal contract award was issued to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,315.44 Firm Fixed Price delivery order is for the provision of various pharmaceutical products and medical supplies to support Department of Defense (DoD) facilities and programs. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.05 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,476.30 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp's Corporate Office Division. The $17,443.08 firm-fixed-price delivery order is for the provision of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other government agencies. AmerisourceBergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUVQ8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,426.39 firm fixed price delivery order is for the provision of 4564160693 MENQUADFI VIAL 0.5ML pharmaceutical products. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The current delivery order was not set aside for any particular business type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 4/3/24 |